Liposome uptake by human leukocytes. Enhancement of entry mediated by human serum and aggregated immunoglobulins
- PMID: 7225420
Liposome uptake by human leukocytes. Enhancement of entry mediated by human serum and aggregated immunoglobulins
Abstract
The entry of immunoglobulin-coated liposomes into human leukocytes bearing Fc receptors was evaluated using two methods: (i) the cellular association of liposomal markers (3H-labelled phosphatidylcholine, lipid phase; [14C]inulin, aqueous phase), and (ii) the ultrastructural cytochemistry of cells following incubation of cells with liposomes containing a cytochemical marker (horseradish peroxidase) in the aqueous spaces. The entry of liposomes into a cell population composed predominantly of neutrophils was linear for 10--15 min and was mediated by an active process that appeared to be both energy- and surface-dependent. This uptake could be largely inhibited by incubation at 0 degrees C, and by exposure to glutaraldehyde, iodoacetamide, N-ethylmaleimide, and an excess of aggregated immunoglobulins. Entry into cells of multilamellar liposomes was saturable, displaying affinity constants of 1.1 and 1.7 mM. Ultrastructural analysis of the heterogeneous leukocyte population showed that monocytes took up liposomes more actively than neutrophils and lymphocytes. Moreover, liposomes were almost always found within the leukocytes, rather than adherent to the outer plasma membrane. The relative avidity of monocytes was confirmed by comparing the uptake of radiolabelled liposomes by a 'pure' neutrophil population, a 'mixed' neutrophil population, and a 'mononuclear cell' population. Precoating liposomes with high molecular weight aggregates of human immunoglobulin G resulted in enhanced serum-independent uptake. The fraction of aggregated immunoglobulin G which was most effective in provoking uptake of coated liposomes also stimulated the greatest amount of lysosomal enzyme secretion. These data suggest that the interaction (precoating) of liposomes with either high molecular weight aggregates of immunoglobulin G or with serum enhances their subsequent uptake by human leukocytes.
Similar articles
-
Interaction of liposomes with human leukocytes in whole blood.Biochim Biophys Acta. 1983 Feb 16;762(1):119-27. doi: 10.1016/0167-4889(83)90124-6. Biochim Biophys Acta. 1983. PMID: 6830865
-
Introduction of purified hexosaminidase A into Tay-Sachs leukocytes by means of immunoglobulin-coated liposomes.Biochemistry. 1976 Jan 27;15(2):452-60. doi: 10.1021/bi00647a034. Biochemistry. 1976. PMID: 1247530
-
Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro.Exp Cell Res. 1987 Jan;168(1):105-15. doi: 10.1016/0014-4827(87)90420-4. Exp Cell Res. 1987. PMID: 3023116
-
Interaction of antibody-bearing small unilamellar liposomes with antigen-coated cells. The effect of antibody and antigen concentration on the liposomal and cell surface respectively.Biochem J. 1981 Nov 15;200(2):211-6. doi: 10.1042/bj2000211. Biochem J. 1981. PMID: 6176223 Free PMC article.
-
Interaction of liposomes with Kupffer cells in vitro.Exp Cell Res. 1984 Jan;150(1):161-76. doi: 10.1016/0014-4827(84)90711-0. Exp Cell Res. 1984. PMID: 6692845
Cited by
-
Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice.Cancer Chemother Pharmacol. 1994;34(2):137-46. doi: 10.1007/BF00685931. Cancer Chemother Pharmacol. 1994. PMID: 8194164
-
Strategic advances in liposomes technology: translational paradigm in transdermal delivery for skin dermatosis.J Nanobiotechnology. 2025 Aug 21;23(1):576. doi: 10.1186/s12951-025-03660-z. J Nanobiotechnology. 2025. PMID: 40835930 Free PMC article. Review.
-
Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.J Control Release. 2018 Sep 28;286:85-93. doi: 10.1016/j.jconrel.2018.07.031. Epub 2018 Jul 17. J Control Release. 2018. PMID: 30030182 Free PMC article.
-
Immunoglobulins as targeting agents for liposome encapsulated drugs.Pharm Weekbl Sci. 1983 Dec 16;5(6):269-80. doi: 10.1007/BF02074854. Pharm Weekbl Sci. 1983. PMID: 6364035 Review.
-
Inhibition of human neutrophil elastase activity by encapsulated serum (Serumsome) therapy.Appl Biochem Biotechnol. 1984;10:309-12. doi: 10.1007/BF02783765. Appl Biochem Biotechnol. 1984. PMID: 6570086
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources